Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.1.1.7 (acetylcholinesterase)
 28,390 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The major findings and conclusions of this study are the following: Indirect evidence for the presence of the bronchoconstrictive transmitter acetylcholine in the human bronchial smooth muscle was obtained by demonstration of acetylcholinesterase-positive nerve fibers and nerve profiles of cholinergic type. Acetylcholinesterase-positive nerve fibers and nerve profiles of cholinergic type were found in human bronchial glands. A sparse adrenergic innervation of the human bronchial smooth muscle and glands was found by using catecholamine histofluorescence. This observation was supported by finding ultrastructurally adrenergic-like nerve profiles close to smooth muscle cells. Direct evidence for the presence of a new possible bronchodilating transmitter VIP (vasoactive intestinal peptide) in the human bronchial smooth muscle was obtained both by light microscopical demonstration of VIP immunoreactive nerve fibers and by localization of VIP like immunoreactivity in granules in nerve profiles. Nerve fibers containing VIP-immunoreactivity were found in the human bronchial glands by light microscopy. Substance P-immunoreactive nerves were found in the lower respiratory tract of the rabbit but not of man by light microscopy. Intraepithelial nerves were demonstrated in man from trachea to segmental bronchi and their concentration was established. The intraepithelial nerves seem to have two predominant locations: either close to the airway lumen or near the basement membrane. Nerves near the lumen were found only in larger airways e.g. trachea and lobar bronchi.
 ...
PMID:Autonomic innervation of the human respiratory tract as revealed by histochemical and ultrastructural methods. 241 Feb 88

The interactions between dopamine and muscarinic receptor subtypes coupled to adenylate cyclase in superfused rat neostriatal slices were investigated using the efflux of cyclic AMP, in the presence of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine, as a highly sensitive parameter of cyclic AMP production. Cyclic AMP efflux induced by simultaneous activation of (stimulatory) D-1 and (inhibitory) D-2 dopamine receptors by dopamine was reduced profoundly by the muscarinic receptor agonist oxotremorine and by inhibition of acetylcholinesterase with physostigmine, but not by the M-1 muscarinic receptor agonist McN-A-343. In contrast, upon blockade of D-2 receptors with (-)-sulpiride, dopamine-stimulated cyclic AMP efflux was inhibited by oxotremorine and physostigmine as well as by McN-A-343. Cyclic AMP efflux induced by isoprenaline, adenosine or vasoactive intestinal peptide was not affected by oxotremorine. The M-1 receptor-selective antagonist pirenzepine, unlike the nonselective antagonist atropine, was about 10 times less potent in antagonizing the inhibitory effects of (a near-maximally effective concentration of) oxotremorine upon simultaneous D-1 and D-2 receptor activation that upon selective D-1 receptor activation (i.e., upon blockade of D-2 receptors). In the latter case, pirenzepine was about 5 times more effective as an antagonist when muscarinic receptors were activated by McN-A-343 than upon exposure of the slices to oxotremorine or physostigmine, whereas the potency of atropine was independent of the agonist used.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors. 245 77

The innervation of cerebral blood vessels by nerve fibers containing acetylcholinesterase (AChE) and vasoactive intestinal peptide (VIP) and the vasomotor effects of the two neurotransmitters have been analyzed in the rat following the uni- or bilateral removal of the sphenopalatine ganglion (SPG), which is thought to be the major origin of this innervation. Histochemistry of AChE-positive nerve fibers and the immunoreactivity toward VIP revealed only a 30% reduction in the innervation pattern of the rostral part of the cerebral circulation following the operation. At approximately 4 weeks postoperatively, the original nerve network was restored. Quantitative measurements of cholineacetyltransferase activity and VIP revealed similar reductions in the levels of collected large cerebral arteries at the base of the brain and in small pial vessels overlying the cerebral cortex at the various postoperative times following uni- or bilateral removal of the SPG. The two techniques thus complemented each other. Vasomotor reactivity to acetylcholine (ACh) and VIP was examined in proximal segments of the middle cerebral artery at the various postoperative times. Generally, the removal of the SPG had no effect on the responses to ACh or VIP. The evidence indicates that only approximately one-third of the cholinergic/VIP innervation of the rostral part of the cerebral circulation originates in the SPG.
 ...
PMID:Acetylcholine and vasoactive intestinal peptide in cerebral blood vessels: effect of extirpation of the sphenopalatine ganglion. 292 Dec 95

Numerous nerve fibres containing vasoactive intestinal peptide (VIP), substance P (SP) or immunoreactive avian pancreatic polypeptide (APP) occur in the nasal mucosa of several mammals, including man. Generally, the nerve fibres are distributed around small blood vessels and seromucous glands. In addition, SP containing fibres can be seen in the nasal epithelium. The pterygopalatine ganglion contains acetylcholinesterase (AChE) positive nerve cell bodies together with VIP and SP containing ones. After exposure to colchicine it could be shown that the VIP and SP containing nerve cell bodies also were positive for AChE. VIP and SP are potant mediators of atropine resistent vasodilatation in the mucosa. The physiological effects of APP are not known.
 ...
PMID:Peptide containing nerves in the nasal mucosa. 616 79

The in vitro action of thyrotropin-releasing hormone (TRH) on the cyclic AMP level and iodine metabolism in dog thyroid, has been studied. TRH inhibited cyclic AMP accumulation and subsequent secretion in slices stimulated by thyrotropic hormone (TSH), prostaglandin E1, cholera toxin and to a lesser extent forskolin. The effect of TRH was suppressed in a medium deprived of calcium or in the presence of isobutylmethylxanthine. TRH also stimulated iodide binding to proteins, but not cyclic GMP accumulation. Although all these characteristics of TRH action on dog thyroid fit those of prostaglandin F1 alpha in this tissue, TRH effects were not relieved by indomethacine. The possibility of a TRH action through other known inhibitors of the cyclic AMP system in dog thyroid such as: acetylcholine, alpha-adrenergic agents, adenosine, iodide were checked and ruled out. The possible involvement of other neurotransmitters, such as ATP or vasoactive intestinal peptide were studied but could not be substantiated. Our data suggest the existence of a direct negative action of TRH on the thyroid itself besides its stimulatory role at the pituitary level. The great variability of the TRH effect was overcome by pretreatment of the dog by pyridostigmine, an acetylcholinesterase inhibitor.
 ...
PMID:Effect of thyrotropin-releasing hormone on dog thyroid in vitro. 619 95

Addition of vasoactive intestinal peptide (VIP) to brain homogenates increased the activity of choline acetyltransferase (ChAT) but not that of acetylcholinesterase or glucose-6-phosphate dehydrogenase. Activity of ChAT was increased in the anterior hypothalamus and in the dorsal and ventral hippocampus, but not in the parietal cortex or posterior hypothalamus. Increased activity occurred rapidly after VIP addition to homogenates and was maximal at 10(-7)M concentration. Kinetic analysis indicates that the Vmax of the enzyme is increased and the Km for choline, but not acetyl-coenzyme A, is decreased in the presence of VIP. Results support a possible VIP-cholinergic interaction in the CNS.
 ...
PMID:Activation of choline acetyltransferase by vasoactive intestinal peptide. 632 60

Previous studies of the development of cholinergic sympathetic innervation of sweat glands in rat footpads suggested that these terminals initially exhibit noradrenergic properties which are lost as the glands and their innervation mature. We have treated neonatal and adult rats with 6-hydroxydopamine (6-OHDA), a toxic congener of norepinephrine, and compared its effects on the cholinergic sympathetic innervation of sweat glands and the noradrenergic sympathetic innervation of the iris, salivary gland, and blood vessels. As reported by others, 6-OHDA treatment of neonates caused the destruction of noradrenergic fibers in the iris and salivary gland but did not affect other fibers projecting to these targets that stain for acetylcholinesterase (AChE). We found that 6-OHDA treatment of neonatal animals also caused the destruction of the sympathetic axons in immature sweat glands that possess catecholamine histofluorescence and tyrosine-hydroxylase-like immunoreactivity. Furthermore, when such animals were examined as adults, we found no AChE staining, vasoactive intestinal peptide (VIP)-like immunoreactivity, or characteristic sympathetic axonal varicosities. However, the denervated glands were invested by a plexus of sensory axons, some of which exhibited substance P-like immunoreactivity (SP-IR). An increase in the number of SP-IR fibers also occurred in the sympathetically denervated irides of these animals. Chronic treatment of neonates with guanethidine, another adrenergic sympathetic neurotoxin, resulted in similar loss of cholinergic sweat gland innervation. Treatment of adults rats with doses of 6-OHDA identical to those used to treat neonates caused the loss of noradrenergic fibers from the iris, salivary gland, and many blood vessels but did not noticeably affect AChE and VIP staining or axonal ultrastructure in the sweat glands. However, treatment with higher doses of 6-OHDA did cause significant axonal degeneration. The response of the sympathetic innervation of developing but not mature sweat glands to 6-OHDA provides evidence for a transition from noradrenergic to cholinergic phenotype during the development of sympathetic neurons in vivo similar to the transition observed in cell culture. The sprouting of sensory axons may be caused by NGF-like trophic influences present in some sympathetically denervated tissues.
 ...
PMID:Neonatal 6-hydroxydopamine treatment eliminates cholinergic sympathetic innervation and induces sensory sprouting in rat sweat glands. 642 23

Capsaicin has been shown to specifically deplete substance P from primary sensory afferents, including sensory nerves innervating blood vessels of the cerebral circulation as well as other vascular beds. In order to further document the specificity of this treatment, we examined the effect of capsaicin treatment on 3 other types of nerves in the guinea pig. Four tissues were examined: cerebral arteries, the mesenteric artery, the heart and iris. Norepinephrine content was not altered after capsaicin treatment, confirming that adrenergic nerves are unaffected. As indices of cholinergic nerves, activities of choline acetyltransferase and acetylcholinesterase were also unchanged after capsaicin treatment. In addition, no significant differences in levels of vasoactive intestinal peptide in cerebral arteries and the heart were found in animals treated with capsaicin. These findings underscore the specificity of capsaicin treatment for substance P containing nerves.
 ...
PMID:Specificity of capsaicin treatment in the cerebral vasculature. 647 98

Most principal neurons in sympathetic ganglia are noradrenergic. A small population, especially those that innervate sweat glands in rat footpads, are cholinergic. We have characterized the innervation of the glands in adult and developing rats to determine whether sympathetic neurons undergo a transition from noradrenergic to cholinergic during normal development as has been observed in culture. In adult rats, the fibers innervating sweat glands exhibited strong acetylcholinesterase (AChE) staining and vasoactive intestinal peptide (VIP)-like immunoreactivity. None of the axons contained endogenous catecholamines detectable with formaldehyde-induced fluorescence or permanganate fixation. However, like cholinergic sympathetic neurons in culture, all axons could take up and store exogenous catecholamine. The sweat glands and their innervation develop postnatally. At 7 days, the axons innervating sweat glands possessed endogenous catecholamine histofluorescence and small granular vesicles but not AChE or VIP. By 14 days, AChE and VIP staining was pronounced. In contrast, catecholamine fluorescence and the number of small granular vesicles were reduced, and by 21 days they were absent. Further, neonatal treatment with 6-hydroxydopamine, a toxic norepinephrine congener, resulted in the loss of cholinergic as well as noradrenergic sympathetic innervation. These observations are consistent with a transition from noradrenergic to cholinergic function in vivo.
 ...
PMID:Development of cholinergic sympathetic neurons: evidence for transmitter plasticity in vivo. 683 80

Numerous nerve fibres containing acetylcholinesterase and noradrenaline, as well as avian pancreatic polypeptide-, vasoactive intestinal peptide-, or substance P-like immunoreactivity are observed around arteries in the external carotid rete of the cat. The nerves are located in the adventitial layer close to the media. It is possible that adrenergic, cholinergic and peptidergic nerve fibres may have a strong neurogenic influence on the rete blood vessels.
 ...
PMID:Perivascular nerves in the feline carotid rete. 712 30


<< Previous 1 2 3 4 5 6 Next >>